Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03174158 · ClinicalTrials.gov registry record · Phase 4
A Text Messaging Program for Smokers in Primary Care
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 153
- Enrollment target
NCT03174158: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT03174158 is a Phase 4 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 153 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03174158, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 153 participants
- Enrollment target
Study Summary
This study is a four arm pilot randomized controlled trial testing the effect of a 12 week text messaging intervention and a mailed nicotine medication intervention, alone and in combination to a control condition consisting of brief behavioral advice and usual care. Research Aim 1: To test, in a 4 arm pilot randomized controlled trial (N=50/group), the effect of a text messaging program and mailed nicotine replacement therapy on smoking outcomes and medication use. Hypothesis 1: A text messaging intervention will increase the proportion of smokers making a quit attempt compared to smokers receiving no text messaging. Hypothesis 2: A text messaging intervention will increase adherence to nicotine replacement therapy compared to subjects receiving only 2 weeks of nicotine replacement therapy. Hypothesis 3: A text messaging intervention will increase the rate of biochemically confirmed past 7-day point prevalent tobacco abstinence at end of treatment compared to subjects receiving no text messaging intervention. Hypothesis 4: A text messaging intervention will increase the number of days not smoking compared to subjects receiving no text messaging intervention. Hypothesis 5: A text messaging intervention will decrease the number of cigarettes smoked per day compared to subjects receiving no text messaging intervention.
Interventions
- BEHAVIORAL Text messaging
- DRUG Mailed nicotine replacement therapy
- BEHAVIORAL Brief advice
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2019-02-28 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03174158
The ClinicalTrials.gov registry entry for NCT03174158 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Text messaging is the first listed.
NCT03174158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03174158 about?
NCT03174158 is a clinical study titled "A Text Messaging Program for Smokers in Primary Care". This study is a four arm pilot randomized controlled trial testing the effect of a 12 week text messaging intervention and a mailed nicotine medication intervention, alone and in combination to a control condition consisting of brief behavioral advice and usual care. Research Aim 1: To test, in a 4...
What is the current status of trial NCT03174158?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 153 participants. The study started on 2017-11-06. Estimated completion is 2019-02-28.
What interventions are being tested in trial NCT03174158?
The interventions under investigation include: Text messaging (BEHAVIORAL), Mailed nicotine replacement therapy (DRUG), Brief advice (BEHAVIORAL).
Who is sponsoring clinical trial NCT03174158?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.